000 01586 a2200445 4500
005 20250515121911.0
264 0 _c20080729
008 200807s 0 0 eng d
022 _a1460-2180
024 7 _a10.1093/carcin/bgn122
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStolfi, Carmine
245 0 0 _aMesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phase.
_h[electronic resource]
260 _bCarcinogenesis
_cJun 2008
300 _a1258-66 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xpharmacology
650 0 4 _aBlotting, Western
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aColonic Neoplasms
_xmetabolism
650 0 4 _aGene Expression
_xdrug effects
650 0 4 _aHumans
650 0 4 _aImmunoprecipitation
650 0 4 _aMesalamine
_xpharmacology
650 0 4 _aMice
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aS Phase
_xdrug effects
650 0 4 _acdc25 Phosphatases
_xbiosynthesis
700 1 _aFina, Daniele
700 1 _aCaruso, Roberta
700 1 _aCaprioli, Flavio
700 1 _aFantini, Massimo Claudio
700 1 _aRizzo, Angelamaria
700 1 _aSarra, Massimiliano
700 1 _aPallone, Francesco
700 1 _aMonteleone, Giovanni
773 0 _tCarcinogenesis
_gvol. 29
_gno. 6
_gp. 1258-66
856 4 0 _uhttps://doi.org/10.1093/carcin/bgn122
_zAvailable from publisher's website
999 _c17989600
_d17989600